+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Forecast 2024-2030- Product Image
Global Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Forecast 2024-2030- Product Image
Sale

Global Insulin Market by Drug (Biologic, Biosimilar), Type (Intermediate-acting Insulin, Long-acting Insulin, Premixed Insulin), Application - Forecast 2024-2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 5337609
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Insulin Market size was estimated at USD 43.64 billion in 2023, USD 46.76 billion in 2024, and is expected to grow at a CAGR of 7.63% to reach USD 73.03 billion by 2030.

The insulin market encompasses the production, distribution, and consumption of various insulin types used to treat diabetes mellitus, a chronic metabolic disorder affecting millions worldwide. The primary application of insulin is to control blood sugar levels in patients with type 1 diabetes who lack natural insulin production and those with type 2 diabetes who have developed insufficient or insufficient insulin release. The scope of this market includes human insulin, modern insulins such as rapid-acting and long-acting, and biosimilar insulins.

Increasing prevalence of diabetes due to aging populations, improved access to healthcare services, increased awareness about diabetes management, and supportive government initiatives to expand the use and production of insulin. On the other hand, the high cost of insulin and the complex regulatory environment hinder the market growth. However, advancements in biotechnology, which have led to development of novel insulins and increasing approval rates, are expected to proliferate the market growth in the coming years.

Regional Insights

In the Americas region, North America dominates the insulin market due to the presence of key players, better healthcare infrastructure, and increased awareness regarding disease management. Factors such as government initiatives for early diagnosis and treatment of diabetes are also contributing significantly to this growth. South America is witnessing rising cases of diabetes amidst its rapidly aging population. Countries such as Mexico and Brazil have introduced national policies focusing on preventing and controlling non-communicable diseases, including diabetes, further accelerating market expansion in the region.

The Asia-Pacific region is fast emerging as a major market for insulin due to its improvements in healthcare infrastructure and product availability. Furthermore, APAC countries have invested heavily in research and development to produce cost-effective insulin products. In recent years, there has been a surge in the adoption of advanced insulin delivery systems, such as insulin pens and pumps, in the region. As more people become aware of diabetes management options, the demand for insulin and associated devices is projected to increase across APAC countries. Western Europe’s insulin market is growing rapidly due to its well-established healthcare infrastructure and increased accessibility to innovative insulin therapies. In the Middle East and Africa region, improving healthcare infrastructure and efforts made by government and international organizations support insulin market growth. Countries such as South Africa are introducing policies to combat non-communicable diseases, including diabetes, through health promotion strategies, which could drive market growth in this area.

Market Trends by Segment

  • Drug: Significant use of biologic drugs due to having safety, efficacy, and innovative features
  • Type: Long-acting insulins provide basal coverage for an extended duration
  • Application: Extensive use of insulin by type I diabetic patients requires constant monitoring and timely administration of insulin

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

Insulin Maker GeneSys to Invest USD 50-60 MN to Set Up Plant in Hyderabad

GeneSys Biologics has announced making a significant investment of USD 50-60 million to establish a state-of-the-art recombinant bulk manufacturing facility in Genome Valley, India, primarily focusing on insulin analogs production. The Hyderabad-based company has already allocated around USD 50 million to develop its Genome Valley plant. To ensure affordability and accessibility, GeneSys has partnered with Civica Inc., a reputable non-profit generic drug company based in the United States. This collaboration aims to manufacture and distribute affordable insulin.

Gulf Pharmaceutical Industries 'Julphar' Signs Landmark Agreement with Sunshine Lake Pharma to Pioneer Insulin Biosimilar Manufacturing in MENA

Gulf Pharmaceutical Industries (Julphar) entered into a strategic licensing agreement with Sunshine Lake Pharma Co., Ltd., a Chinese pharmaceutical company. This agreement is a significant milestone for Julphar as it grants them the license and technology transfer of Insulin Glargine and Insulin Aspart products, specifically for managing type I and type II diabetes. By leveraging this agreement, Julphar is effectively expanding its diabetes medication portfolio and introducing modern Insulin biosimilar products to the region.

Sanofi Launches New Long-Acting Insulin Drug in India

Sanofi S.A. has recently obtained marketing authorization from the Central Drugs Standard Control Organization for its diabetes treatment drug, Soliqua, in India. This medication is specifically designed for adults with type 2 diabetes and obesity who have inadequate control over their condition through oral or injectable therapies. Soliqua combines insulin glargine and lixisenatide in fixed-ratio combinations of 10-40 and 30-60, respectively.

Key Company Profiles

The report delves into recent significant developments in the Insulin Market, highlighting leading vendors and their innovative profiles. These include ADOCIA, AstraZeneca PLC, Baxter International, Inc., Biocon Limited, Bioton S.A., CardioVends, Eli Lilly and Company, Eva Pharma, GeneSys Biologics, Glenmark Pharmaceuticals Ltd., Gulf Pharmaceutical Industries (Julphar), MannKind Corporation, Merck & Co., Inc., MJ Biopharm Pvt. Ltd., Novartis AG, Novo Nordisk A/S, Oramed Pharmaceuticals Inc., Pfizer Inc., Sanofi Group, Tonghua Dongbao Pharmaceutical Co., Ltd., Viatris Inc., Wockhardt Limited, and Zealand Pharma A/S.

This research report offers invaluable insights into various crucial aspects of the Insulin Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising incidence of diabetes and obesity with increasing geriatric population
5.1.1.2. Rapid development in insulin delivery systems
5.1.1.3. Favorable reimbursement policies for insulin products in developed countries
5.1.2. Restraints
5.1.2.1. High cost associated with insulin drugs
5.1.3. Opportunities
5.1.3.1. Potential investments in R&D activities for insulin development
5.1.3.2. Rising approvals for interchangeable biosimilar insulin products
5.1.4. Challenges
5.1.4.1. Complex regulatory landscape and problems related to patient adherence to treatment regimens
5.2. Market Segmentation Analysis
5.2.1. Drug: Significant use of biologic drugs due to having safety, efficacy, and innovative features
5.2.2. Type: Long-acting insulins provide basal coverage for an extended duration
5.2.3. Application: Extensive use of insulin by type I diabetic patients requires constant monitoring and timely administration of insulin
5.3. Market Trend Analysis
5.3.1. Established healthcare infrastructure and development of affordable product have supplemented market growth across the Americas
5.3.2. Government support to increase accessibility and usage of insulin in APAC region
5.3.3. Research & development activities and availability of reimbursement policies for insulin in the EMEA region
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
6. Insulin Market, by Drug
6.1. Introduction
6.2. Biologic
6.3. Biosimilar
7. Insulin Market, by Type
7.1. Introduction
7.2. Intermediate-acting Insulin
7.3. Long-acting Insulin
7.4. Premixed Insulin
7.5. Rapid-acting Insulin
7.6. Short-acting Insulin
8. Insulin Market, by Application
8.1. Introduction
8.2. Type I Diabetes
8.3. Type II Diabetes
9. Americas Insulin Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Insulin Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Insulin Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Insulin Maker GeneSys to Invest USD 50-60 MN to Set Up Plant in Hyderabad
12.3.2. Gulf Pharmaceutical Industries 'Julphar' Signs Landmark Agreement with Sunshine Lake Pharma to Pioneer Insulin Biosimilar Manufacturing in MENA
12.3.3. Sanofi Launches New Long-Acting Insulin Drug in India
12.3.4. California, Drugmaker Partner to Produce Affordable Insulin
12.3.5. Novo Nordisk to Launch Once-a-Week Insulin Regime for Indian Patients
12.3.6. ADOCIA Announces the Successful Phase 1 Study for BioChaperone Lispro with Partner Tonghua Dongbao
12.3.7. Glenmark Launches Type 2 Diabetes and High Insulin Resistance Drug in India; Shares Jump
12.3.8. Lilly and EVA Pharma Announce Collaboration to Enhance Sustainable Access to Affordable Insulin in Africa
12.3.9. Novo Nordisk Launches Unbranded Biologic of Tresiba Analog Insulin to Expand Affordability Options for Patients
12.3.10. Optum, Sanofi Partner on Low Cost Insulin for the Uninsured
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. INSULIN MARKET RESEARCH PROCESS
FIGURE 2. INSULIN MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INSULIN MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INSULIN MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL INSULIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. INSULIN MARKET DYNAMICS
FIGURE 7. GLOBAL INSULIN MARKET SIZE, BY DRUG, 2023 VS 2030 (%)
FIGURE 8. GLOBAL INSULIN MARKET SIZE, BY DRUG, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INSULIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL INSULIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INSULIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. GLOBAL INSULIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. INSULIN MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. INSULIN MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. INSULIN MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INSULIN MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL INSULIN MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL INSULIN MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL INSULIN MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL INSULIN MARKET SIZE, BY BIOLOGIC, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL INSULIN MARKET SIZE, BY BIOLOGIC, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL INSULIN MARKET SIZE, BY BIOSIMILAR, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL INSULIN MARKET SIZE, BY BIOSIMILAR, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL INSULIN MARKET SIZE, BY INTERMEDIATE-ACTING INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL INSULIN MARKET SIZE, BY INTERMEDIATE-ACTING INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL INSULIN MARKET SIZE, BY LONG-ACTING INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL INSULIN MARKET SIZE, BY LONG-ACTING INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL INSULIN MARKET SIZE, BY PREMIXED INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL INSULIN MARKET SIZE, BY PREMIXED INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL INSULIN MARKET SIZE, BY RAPID-ACTING INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL INSULIN MARKET SIZE, BY RAPID-ACTING INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL INSULIN MARKET SIZE, BY SHORT-ACTING INSULIN, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL INSULIN MARKET SIZE, BY SHORT-ACTING INSULIN, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL INSULIN MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL INSULIN MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL INSULIN MARKET SIZE, BY TYPE II DIABETES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL INSULIN MARKET SIZE, BY TYPE II DIABETES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. AMERICAS INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 32. AMERICAS INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 33. AMERICAS INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 34. AMERICAS INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 35. AMERICAS INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 36. AMERICAS INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 37. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 38. AMERICAS INSULIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 39. ARGENTINA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 40. ARGENTINA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 41. ARGENTINA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 42. ARGENTINA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 43. ARGENTINA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 44. ARGENTINA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 45. BRAZIL INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 46. BRAZIL INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 47. BRAZIL INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 48. BRAZIL INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 49. BRAZIL INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 50. BRAZIL INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 51. CANADA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 52. CANADA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 53. CANADA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 54. CANADA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 55. CANADA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 56. CANADA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 57. MEXICO INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 58. MEXICO INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 59. MEXICO INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 60. MEXICO INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 61. MEXICO INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 62. MEXICO INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 63. UNITED STATES INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 64. UNITED STATES INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 65. UNITED STATES INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 66. UNITED STATES INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 67. UNITED STATES INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 68. UNITED STATES INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 69. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 70. UNITED STATES INSULIN MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 71. ASIA-PACIFIC INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 72. ASIA-PACIFIC INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 73. ASIA-PACIFIC INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. ASIA-PACIFIC INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 76. ASIA-PACIFIC INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 78. ASIA-PACIFIC INSULIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 79. AUSTRALIA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 80. AUSTRALIA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 81. AUSTRALIA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. AUSTRALIA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. AUSTRALIA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 84. AUSTRALIA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 85. CHINA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 86. CHINA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 87. CHINA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 88. CHINA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 89. CHINA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 90. CHINA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 91. INDIA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 92. INDIA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 93. INDIA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 94. INDIA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 95. INDIA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 96. INDIA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 97. INDONESIA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 98. INDONESIA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 99. INDONESIA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 100. INDONESIA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 101. INDONESIA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 102. INDONESIA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 103. JAPAN INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 104. JAPAN INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 105. JAPAN INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 106. JAPAN INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 107. JAPAN INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 108. JAPAN INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 109. MALAYSIA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 110. MALAYSIA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 111. MALAYSIA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 112. MALAYSIA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 113. MALAYSIA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 114. MALAYSIA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 115. PHILIPPINES INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 116. PHILIPPINES INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 117. PHILIPPINES INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 118. PHILIPPINES INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 119. PHILIPPINES INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 120. PHILIPPINES INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 121. SINGAPORE INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 122. SINGAPORE INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 123. SINGAPORE INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 124. SINGAPORE INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 125. SINGAPORE INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 126. SINGAPORE INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 127. SOUTH KOREA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 128. SOUTH KOREA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 129. SOUTH KOREA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 130. SOUTH KOREA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 131. SOUTH KOREA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 132. SOUTH KOREA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 133. TAIWAN INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 134. TAIWAN INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 135. TAIWAN INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 136. TAIWAN INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 137. TAIWAN INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 138. TAIWAN INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 139. THAILAND INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 140. THAILAND INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 141. THAILAND INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 142. THAILAND INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 143. THAILAND INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 144. THAILAND INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 145. VIETNAM INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 146. VIETNAM INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 147. VIETNAM INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 148. VIETNAM INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 149. VIETNAM INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 150. VIETNAM INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA INSULIN MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 159. DENMARK INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 160. DENMARK INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 161. DENMARK INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. DENMARK INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. DENMARK INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 164. DENMARK INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 165. EGYPT INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 166. EGYPT INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 167. EGYPT INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 168. EGYPT INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 169. EGYPT INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 170. EGYPT INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 171. FINLAND INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 172. FINLAND INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 173. FINLAND INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 174. FINLAND INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 175. FINLAND INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 176. FINLAND INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 177. FRANCE INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 178. FRANCE INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 179. FRANCE INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 180. FRANCE INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 181. FRANCE INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 182. FRANCE INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 183. GERMANY INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 184. GERMANY INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 185. GERMANY INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 186. GERMANY INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 187. GERMANY INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 188. GERMANY INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 189. ISRAEL INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 190. ISRAEL INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 191. ISRAEL INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 192. ISRAEL INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 193. ISRAEL INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 194. ISRAEL INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 195. ITALY INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 196. ITALY INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 197. ITALY INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 198. ITALY INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 199. ITALY INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 200. ITALY INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 201. NETHERLANDS INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 202. NETHERLANDS INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 203. NETHERLANDS INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 204. NETHERLANDS INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 205. NETHERLANDS INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 206. NETHERLANDS INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 207. NIGERIA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 208. NIGERIA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 209. NIGERIA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 210. NIGERIA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 211. NIGERIA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 212. NIGERIA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 213. NORWAY INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 214. NORWAY INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 215. NORWAY INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 216. NORWAY INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 217. NORWAY INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 218. NORWAY INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 219. POLAND INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 220. POLAND INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 221. POLAND INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 222. POLAND INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 223. POLAND INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 224. POLAND INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 225. QATAR INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 226. QATAR INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 227. QATAR INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 228. QATAR INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 229. QATAR INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 230. QATAR INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 231. RUSSIA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 232. RUSSIA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 233. RUSSIA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 234. RUSSIA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 235. RUSSIA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 236. RUSSIA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 237. SAUDI ARABIA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 238. SAUDI ARABIA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 240. SAUDI ARABIA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 242. SAUDI ARABIA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 243. SOUTH AFRICA INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 244. SOUTH AFRICA INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 246. SOUTH AFRICA INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 248. SOUTH AFRICA INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 249. SPAIN INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 250. SPAIN INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 251. SPAIN INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 252. SPAIN INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 253. SPAIN INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 254. SPAIN INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 255. SWEDEN INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 256. SWEDEN INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 257. SWEDEN INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 258. SWEDEN INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 259. SWEDEN INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 260. SWEDEN INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 261. SWITZERLAND INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 262. SWITZERLAND INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 263. SWITZERLAND INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 264. SWITZERLAND INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 265. SWITZERLAND INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 266. SWITZERLAND INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 267. TURKEY INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 268. TURKEY INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 269. TURKEY INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 270. TURKEY INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 271. TURKEY INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 272. TURKEY INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM INSULIN MARKET SIZE, BY DRUG, 2018-2023 (USD MILLION)
TABLE 280. UNITED KINGDOM INSULIN MARKET SIZE, BY DRUG, 2024-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM INSULIN MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 282. UNITED KINGDOM INSULIN MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM INSULIN MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
TABLE 284. UNITED KINGDOM INSULIN MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
TABLE 285. INSULIN MARKET SHARE, BY KEY PLAYER, 2023
TABLE 286. INSULIN MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • ADOCIA
  • AstraZeneca PLC
  • Baxter International, Inc.
  • Biocon Limited
  • Bioton S.A.
  • CardioVends
  • Eli Lilly and Company
  • Eva Pharma
  • GeneSys Biologics
  • Glenmark Pharmaceuticals Ltd.
  • Gulf Pharmaceutical Industries (Julphar)
  • MannKind Corporation
  • Merck & Co., Inc.
  • MJ Biopharm Pvt. Ltd.
  • Novartis AG
  • Novo Nordisk A/S
  • Oramed Pharmaceuticals Inc.
  • Pfizer Inc.
  • Sanofi Group
  • Tonghua Dongbao Pharmaceutical Co., Ltd.
  • Viatris Inc.
  • Wockhardt Limited
  • Zealand Pharma A/S

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 46.76 Billion
Forecasted Market Value ( USD ) by 2030 $ 73.03 Billion
Compound Annual Growth Rate7.6%
Regions CoveredGlobal
No. of Companies Mentioned23

Related Topics

Related Reports

Global Human Insulin Drugs Market by Insulin Type (Basal or Long-Acting Insulins, Biosimilar Insulins, Intermediate-Acting Insulin), Delivery Devices (Insulin Pens, Insulin Pumps, Insulin Syringes), Application, Distribution Channel - Forecast 2024-2030 - Product Image

Global Human Insulin Drugs Market by Insulin Type (Basal or Long-Acting Insulins, Biosimilar Insulins, Intermediate-Acting Insulin), Delivery Devices (Insulin Pens, Insulin Pumps, Insulin Syringes), Application, Distribution Channel - Forecast 2024-2030

  • Report
  • 192 Pages
  • Global
From
Global Type 1 Diabetes Drug Market by Form (Insulin Therapy, Oral Medication), End User (Drugstore, Hospital) - Forecast 2024-2030 - Product Image

Global Type 1 Diabetes Drug Market by Form (Insulin Therapy, Oral Medication), End User (Drugstore, Hospital) - Forecast 2024-2030

  • Report
  • 194 Pages
  • Global
From
Insulin Storage Devices Market Size, Share & Trends Analysis Report By Device Type (Insulated Kits, Battery Operated), By Patient Type (Diabetes Type 1, Diabetes Type 2), By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Insulin Storage Devices Market Size, Share & Trends Analysis Report By Device Type (Insulated Kits, Battery Operated), By Patient Type (Diabetes Type 1, Diabetes Type 2), By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 110 Pages
  • Global
From
Insulin Patch Pumps Market Size, Share & Trends Analysis Report By Delivery Mode (Basal, Bolus, Basal & Bolus), By Product Type (Disposable, Reusable), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Insulin Patch Pumps Market Size, Share & Trends Analysis Report By Delivery Mode (Basal, Bolus, Basal & Bolus), By Product Type (Disposable, Reusable), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 110 Pages
  • Global
From
Insulin biosimilars Global Market Report 2024 - Product Image

Insulin biosimilars Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From

About the Insulin Market

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump. The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.